Comparative Effectiveness of Implementation Strategies for Blood Pressure Control in Hypertensive Patients: A Systematic Review and Meta-analysis

Katherine T Mills, Katherine M Obst, Wei Shen, Sandra Molina, Hui-Jie Zhang, Hua He, Lisa A Cooper, Jiang He, Katherine T Mills, Katherine M Obst, Wei Shen, Sandra Molina, Hui-Jie Zhang, Hua He, Lisa A Cooper, Jiang He

Abstract

Background: The prevalence of hypertension is high and is increasing worldwide, whereas the proportion of controlled hypertension is low.

Purpose: To assess the comparative effectiveness of 8 implementation strategies for blood pressure (BP) control in adults with hypertension.

Data sources: Systematic searches of MEDLINE and Embase from inception to September 2017 with no language restrictions, supplemented with manual reference searches.

Study selection: Randomized controlled trials lasting at least 6 months comparing the effect of implementation strategies versus usual care on BP reduction in adults with hypertension.

Data extraction: Two investigators independently extracted data and assessed study quality.

Data synthesis: A total of 121 comparisons from 100 articles with 55 920 hypertensive patients were included. Multilevel, multicomponent strategies were most effective for systolic BP reduction, including team-based care with medication titration by a nonphysician (-7.1 mm Hg [95% CI, -8.9 to -5.2 mm Hg]), team-based care with medication titration by a physician (-6.2 mm Hg [CI, -8.1 to -4.2 mm Hg]), and multilevel strategies without team-based care (-5.0 mm Hg [CI, -8.0 to -2.0 mm Hg]). Patient-level strategies resulted in systolic BP changes of -3.9 mm Hg (CI, -5.4 to -2.3 mm Hg) for health coaching and -2.7 mm Hg (CI, -3.6 to -1.7 mm Hg) for home BP monitoring. Similar trends were seen for diastolic BP reduction.

Limitation: Sparse data from low- and middle-income countries; few trials of some implementation strategies, such as provider training; and possible publication bias.

Conclusion: Multilevel, multicomponent strategies, followed by patient-level strategies, are most effective for BP control in patients with hypertension and should be used to improve hypertension control.

Primary funding source: National Institutes of Health.

Figures

Figure 1
Figure 1
Flowchart of Study Selection
Figure 2. Adjusted Mean Net Reduction in…
Figure 2. Adjusted Mean Net Reduction in Blood Pressure Associated with Implementation Strategies
Mean net reduction in systolic blood pressure (upper panel) and diastolic blood pressure (lower panel). Mean net reductions estimated using generalized estimating equations and adjusted for sex, age, baseline systolic (or diastolic) blood pressure, trial duration, type of control group, and all other intervention strategies. Boxes weighted by sample size.

References

    1. Mills KT, Bundy JD, Kelly TN, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2016;134:441–50.
    1. Forouzanfar MH, Liu P, Roth GA, et al. Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990–2015. JAMA. 2017;317:165–82.
    1. Gay HC, Rao SG, Vaccarino V, Ali MK. Effects of different dietary interventions on blood pressure: systematic review and meta-analysis of randomized controlled trials. Hypertension. 2016;67:733–9.
    1. Ettehad D, Emdin CA, Kiran A, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387:957–67.
    1. Mills KT, Rubinstein A, Irazola V, et al. Comprehensive approach for hypertension control in low-income populations: rationale and study design for the Hypertension Control Program in Argentina. Am J Med Sci. 2014;348:139–45.
    1. Walsh JME, McDonald KM, Shojania KG, et al. Quality improvement strategies for hypertension management: a systematic review. Medical Care. 2006;44:646–57.
    1. Glynn LG, Murphy AW, Smith SM, et al. Self-monitoring and other non-pharmacological interventions to improve the management of hypertension in primary care: a systematic review. Br J of Gen Pract. 2010 doi: 10.3399/bjgp10X544113.
    1. Omboni S, Guarda A. Impact of home blood pressure telemonitoring and blood pressure control: a meta-analysis of randomized controlled studies. Am J Hypertens. 2011;24:989–98.
    1. Tao D, Xie L, Wang T, et al. A meta-analysis of the use of electronic reminders for patient adherence to medication in chronic disease care. J Telemed Telecare. 2015;21:3–13.
    1. Wolever RQ, Simmons LA, Sforzo GA, et al. A systematic review of the literature on health and wellness coaching: defining a key behavioral intervention in healthcare. Glob Adv Health Med. 2013;2:38–57.
    1. Chan WV, Pearson TA, Bennett GC, et al. ACC/AHA special report: clinical practice guideline implementation strategies: a summary of systematic reviews by the NHLBI Implementation Science Work Group. Circulation. 2017;135:e122–37.
    1. Baik D. Team-based care: a concept analysis. Nurs Forum. doi: 10.1111/nuf.12194. Epub 2016 Dec 9.
    1. Higgins JPT, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.
    1. Sidik K, Jonkman JN. A note on variance estimation in random effects meta-regression. J Biopharm Stat. 2005;15:823–38.
    1. Sidik K, Jonkman JN. Simple heterogeneity variance estimation for meta-analysis. J Royal Stat Soc. 2005;54:367–84.
    1. Knapp G, Hartung J. Improved tests for a random effects meta-regression with a single covariate. Stat Med. 2003;22:2693–710.
    1. Tipton E. Small sample adjustments for robust variance estimation with meta-regression. Psychol Methods. 2015;20:375–93.
    1. Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:15–58.
    1. Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56:455–63.
    1. Whelton PK, Einhorn PT, Muntner P, et al. National Heart, Lung, and Blood Institute Working Group on Research Needs to Improve Hypertension Treatment and Control in African Americans. Research Needs to Improve Hypertension Treatment and Control in African Americans. Hypertension. 2016;68:1066–72.
    1. Committee on Public Health Priorities to Reduce and Control Hypertension in the U.S. Population, Institute of Medicine. A population-based policy and systems change approach to prevent and control hypertension. Washington DC: National Academy Press; 2010.
    1. Santschi V, Chiolero A, Colosimo AL, et al. Improving blood pressure control through pharmacist interventions: a meta-analysis of randomized controlled trials. J Am Heart Assoc. 2014;3:e000718. doi: 10.1161/JAHA.113.000718.
    1. Clark CE, Smith LF, Taylor RS, Campbell JL. Nurse led interventions to improve control of blood pressure in people with hypertension: systematic review and meta-analysis. BMJ. 2010;341:c3995. doi: 10.1136/bmj.c3995.
    1. Carter BL, Rogers M, Daly J, Zheng S, James PA. The potency of team-based care interventions for hypertension: a meta-analysis. Arch Intern Med. 2009;169:1748–55.
    1. Agarwal R, Bills JE, Hecht TJW, Light RP. Role of home blood pressure monitoring in overcoming therapeutic inertia and improving hypertension control: a systematic review and meta-analysis. Hypertension. 2011;57:29–38.
    1. Carter BL, Bosworth HB, Green BB. The hypertension team: the role of the pharmacist, nurse, and teamwork in hypertension therapy. J Clin Hypertens (Greenwich) 2012;14:51–65.
    1. Dehmer SP, Baker-Goering MM, Maciosek MV, et al. Modeled health and economic impact of team-based care for hypertension. Am J Prev Med. 2016;50:S34–44.
    1. Kulchaitanaroaj P, Brooks JM, Chaiyakunapruk N, Goedken AM, Chrischilles EA, Carter BL. Cost-utility analysis of physician-pharmacist collaborative intervention for treating hypertension compared with usual care. J Hypertens. 2017;35:178–87.
    1. Edelman D, Fredrickson SK, Melnyk SD, et al. Medical clinics versus usual care for patients with both diabetes and hypertension: a randomized trial. Ann Intern Med. 2010;152:689–96.
    1. Hunt JS, Siemienczuk J, Pape G, et al. A randomized controlled trial of team-based care: impact of physician-pharmacist collaboration on uncontrolled hypertension. J Gen Intern Med. 2008;23:1966–72.
    1. Margolis KL, Asche SE, Bergdall AR, et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA. 2013;310:46–56.
    1. Carter BL, Coffey CS, Ardery G, et al. Cluster-randomized trial of a physician/pharmacist collaborative model to improve blood pressure control. Circ Cardiovasc Qual Outcomes. 2015;8:235–43.
    1. Carter BL, Bergus GR, Dawson JD, et al. A cluster randomized trial to evaluate physician/pharmacist collaboration to improve blood pressure control. J Clin Hypertens (Greenwich) 2008;10:260–71.
    1. Carter BL, Ardery G, Dawson JD, et al. Physician and pharmacist collaboration to improve blood pressure control. Arch Intern Med. 2009;169:1996–2002.
    1. Rudd P, Houston Miller N, Kaufman J, et al. Nurse management for hypertension: a systems approach. Am J Hypertens. 2004;17:921–7.
    1. Hebert PL, Sisk JE, Tuzzio L, et al. Nurse-led disease management for hypertension control in a diverse urban community: a randomized trial. J Gen Intern Med. 2011;27:630–9.
    1. He J, Irazola V, Mills KT, et al. A cluster randomized trial of a comprehensive approach for hypertension control in low-income patients in Argentina. Circulation. 2016;134:e702–e20.
    1. Jafar TH, Hatcher J, Poulter N, et al. Community-based interventions to promote blood pressure control in a developing country. Ann Intern Med. 2009;151:593–601.
    1. Pladevall M, Brotons C, Gabriel R, et al. Multicenter cluster-randomized trial of a multifactorial intervention to improve antihypertensive medication adherence and blood pressure control among patients at high cardiovascular risk (The COM99 Study) Circulation. 2010;122:1183–91.
    1. Stewart K, George J, McNamara KP, et al. A multifaceted pharmacist intervention to improve antihypertensive adherence: a cluster-randomized, controlled trial (HAPPy trial) J Clin Pharm Ther. 2014;39:527–34.
    1. Kivelä K, Elo S, Kyngäs H, Kääriäinen M. The effects of health coaching on adult patients with chronic diseases: a systematic review. Patient Educ Couns. 2014;97:147–57.
    1. Sim JJ, Handler J, Jacobsen SJ, et al. Systemic implementation strategies to improve hypertension: the Kaiser Permanente Southern California experience. Can J Cardiol. 2014;30:544–52.
    1. Fletcher RD, Amdur Rl, Kolodner R, et al. Blood pressure control among veterans: a large multiyear analysis of blood pressure data from the Veterans Administration health data repository. Circulation. 2012;125:2462–8.
    1. Shaw KM, Handler J, Wall HK, Kanter MH. Improving blood pressure control in a large multiethnic California population through changes in health care delivery, 2004–2012. Prev Chronic Dis. 2015;11:140173.
    1. Cooper LA, Roter DL, Carson KA, et al. A randomized trial to improve patient-centered care and hypertension control in underserved primary care patients. J Gen Intern Med. 2011;26:1297–1304.
    1. Jolles EP, Clark AM, Braam B. Getting the message across: opportunities and obstacles in effective communication in hypertension care. J Hypertens. 2012;30:1500–10.
    1. Tobe SW. The Global Alliance for Chronic Diseases supports 15 major studies in hypertension prevention and control in low- and middle-income countries. J Clin Hypertens. 2016;18:600–5.
    1. Okamoto MP, Nakahiro RK. Pharmacoeconomic evaluation of a pharmacist-managed hypertension clinic. Pharmacotherapy. 2001;21:1337–44.
    1. Soghikian K, Casper SM, Fireman BH, et al. Home blood pressure monitoring: effect on use of medical services and medical care costs. Med Care. 1992;30:855–65.
    1. Anchala R, Kaptoge S, Pant H, et al. Evaluation of effectiveness and cost-effectiveness of a clinical decision support system in managing hypertension in resource constrained primary health care settings: results from a cluster randomized trial. J Am Heart Assoc. 2015;4:3001213.
    1. Parati G, Omboni S, Albini F, et al. Home blood pressure telemonitoring improves hypertension control in general practice. The TeleBPCare study. J Hypertens. 2009;27:198–203.
    1. McManus RJ, Mant J, Bray EP, et al. Telemonitoring and self-management in the control hypertension (TASMINH2): a randomized controlled trial. Lancet. 2010;376:163–72.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner